Therapy: Maintenance of steroid-free remission in nephrotic syndrome

Nature Reviews Nephrology 11, 569 (2015). doi:10.1038/nrneph.2015.117 Authors: Jeroen K. Deegens & Jack F. Wetzels Maintaining steroid-free remission in children with idiopathic nephrotic syndrome is an important goal of therapy. A new trial provides evidence that mycophenolate mofetil can be added to the list of effective steroid-sparing agents. The majority of participants relapsed, however, highlighting an unmet need for more effective treatment modalities.
Source: Nature Reviews Nephrology - Category: Urology & Nephrology Authors: Tags: News and Views Source Type: research